会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • BETA-HAIRPIN PEPTIDOMIMETICS HAVING CXCR4 ANTAGONIZING ACTIVITY
    • 具有CXCR4拮抗活性的BETA-HAIRPIN PEPTIDOMIMETICS
    • WO2010127704A1
    • 2010-11-11
    • PCT/EP2009/055563
    • 2009-05-07
    • POLYPHOR AGOBRECHT, DanielGOMBERT, Frank, OttoLEDERER, AlexanderROMAGNOLI, BarbaraBISANG, Christian
    • OBRECHT, DanielGOMBERT, Frank, OttoLEDERER, AlexanderROMAGNOLI, BarbaraBISANG, Christian
    • C07K7/08C07K7/02A61K38/10A61P29/00A61P31/18A61P35/00
    • C07K7/08C07K1/061C07K7/02
    • β-Hairpin peptidomimetics of the general formula Cyclo(-Xaa 1 -Xaa 2 -Xaa 3 -Cys 4 -Xaa 5 -Xaa 6 -Xaa 7 -Xaa 8 -Arg 9 -Tyr 10 -Cys 11 - Xaa 12 -Xaa 13 -Xaa 14 -Xaa 15 -Xaa 16 -), disulfide bond between Cys 4 and Cys11, and pharmaceutically acceptable salts thereof, with Xaa 1 , Xaa 2 , Xaa 3 , Xaa 5 , Xaa 6 , Xaa 7 , Xaa 8 , Xaa 12 , Xaa 13 , Xaa 14 , Xaa 15 and Xaa 16 being amino acid residues of certain types which are defined in the description and the claims, have CXCR4 antagonizing properties and can be used for preventing HIV infections in healthy individuals or for slowing and halting viral progression in infected patients; or where cancer is mediated or resulting from CXCR4 receptor activity; or where immunological diseases are mediated or resulting from CXCR4 receptor activity; or for treating immunosuppression; or during apheresis collections of peripheral blood stem cells and/or as agents to induce mobilization of stem cells to regulate tissue repair. These peptides can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
    • ß-通式为(Xaa1-Xaa2-Xaa3-Cys4-Xaa5-Xaa6-Xaa7-Xaa8-Arg9-Tyr10-Cys11-Xaa12-Xaa13-Xaa14-Xaa15-Xaa16-)的发夹肽模拟物,Cys4和 Cys11及其药学上可接受的盐与在说明书和权利要求书中定义的某些类型的氨基酸残基的Xaa1,Xaa2,Xaa3,Xaa5,Xaa6,Xaa7,Xaa8,Xaa12,Xaa13,Xaa14,Xaa15和Xaa16具有 CXCR4拮抗性,可用于预防健康个体的艾滋病毒感染,或用于缓解和停止感染患者的病毒进展; 或由CXCR4受体活性介导或产生癌症; 或其中免疫性疾病介导或由CXCR4受体活性产生; 或用于治疗免疫抑制; 或在外周血干细胞的分离采集期间和/或作为诱导干细胞动员调节组织修复的试剂。 这些肽可以通过基于混合固相和溶液相合成策略的方法制造。
    • 7. 发明申请
    • BETA-HAIRPIN PEPTIDOMIMETICS AS SELECTIVE ELASTASE INHIBITORS
    • BETA-HAIRPIN PEPTIDOMIMETICS作为选择性弹性酶抑制剂
    • WO2015096873A1
    • 2015-07-02
    • PCT/EP2013/078073
    • 2013-12-27
    • POLYPHOR AG
    • GOMBERT, Frank OttoOBRECHT, DanielSELLIER-KESSLER, OdileLEDERER, AlexanderLUDIN, ChristianSCHMITT-BILLET, ManuelaWEINBRENNER, Steffen
    • C07K14/81
    • C07K7/64A61K38/00C07K14/811
    • β-Hairpin peptidomimetics of the general formula cyclo(-Xaa 1 -Xaa 2 -Thr 3 -Xaa 4 -Ser 5 -Xaa 6 -Xaa 7 -Xaa 8 -Xaa 9 -Xaa 10 -Xaa 11 -Xaa 12 -Xaa 13 -) and pharmaceutically acceptable salts thereof, with Xaa 1 , Xaa 2 , Xaa 4 , Xaa 6 , Xaa 7 , Xaa 8 , Xaa 9 , Xaa 10 , Xaa 11 , Xaa 12 and Xaa 13 being amino acid residues of certain types which are defined in the description and the claims, have elastase inhibitory properties, especially against human neutrophil elastase, and can be used for preventing infections or diseases related to such infections in healthy individuals or for slowing infections in infected patients. The compounds of the invention can further be used where cancer, or immunological diseases, or pulmonary diseases, or cardiovascular diseases, or neurodegenerative diseases, or inflammation, or diseases related to inflammation, are mediated or resulting from elastase activity. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
    • 通式为(Xaa1-Xaa2-Thr3-Xaa4-Ser5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11-Xaa12-Xaa13-)的β-发夹肽模拟物及其药学上可接受的盐与Xaa1,Xaa2,Xaa4 作为在说明书和权利要求书中定义的某些类型的氨基酸残基的Xaa6,Xaa7,Xaa8,Xaa9,Xaa10,Xaa11,Xaa12和Xaa13具有弹性蛋白酶抑制性质,特别是针对人嗜中性粒细胞弹性蛋白酶,并且可用于预防 感染或与健康个体感染有关的疾病或感染患者感染减缓。 本发明的化合物可以进一步用于由弹性蛋白酶活性介导或由弹性蛋白酶活性介导的癌症或免疫疾病或肺部疾病或心血管疾病或神经变性疾病或炎症或与炎症有关的疾病。 这些肽模拟物可以通过基于混合固相和溶液相合成策略的方法制造。